Interim analysis of STOMP study finds no efficacy for tecovirimat in mild to moderate Mpox cases The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild to moderate clade II mpox and a low risk of developing severe disease, according to an interim data analysis from the international clinical trial called the Study of Tecovirimat for Mpox (STOMP).
https://www.news-medical.net/n....ews/20241210/Interim

Daratumumab treatment shows promise for high-risk smoldering multiple myeloma in phase 3 trial A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM).
https://www.news-medical.net/n....ews/20241210/Daratum

Bed Sores Can Slow Neurological Recovery After Spinal Cord Injury TUESDAY, Dec. 10, 2024 -- Bed sores can be more than debilitating and painful. Now a new study shows they can also dramatically impact a person’s recovery from a spinal cord injury.
“Our study found that patients with pressure ulcers...
https://www.drugs.com/news/bed....-sores-can-slow-neur

Group of Nobel Laureates Press Senate to Reject Kennedy's Nomination TUESDAY, Dec. 10, 2024 -- Robert Kennedy Jr. should not be confirmed to lead the U.S. Department of Health and Human Services, over 75 Nobel laureates urged Monday.
In a letter published by the New York Times, the esteemed scientists took issue...
https://www.drugs.com/news/gro....up-nobel-laureates-p

Wildfire Smoke Is Choking America's Cities -- Is Yours on the List? TUESDAY, Dec. 10, 2024 -- Heavy smoke from wildfires more frequently chokes the skies over the Western United States, but cities farther to the east are no longer being spared, new research shows.
Canada’s unusually intense 2023 wildfire...
https://www.drugs.com/news/wil....dfire-smoke-choking-